Cure SMA Hosts SMA Patient-Focused Drug Development Meeting With FDA
On April 18, Cure SMA hosted a patient-focused drug development meeting with the Food and…
Wendy is a proven blogger and social media manager who has helped to build online communities for businesses and organizations. She currently heads the website’s social outreach online through social media platforms such as Facebook, Twitter, and Pinterest.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
On April 18, Cure SMA hosted a patient-focused drug development meeting with the Food and…
When people think of wonder drugs they think back to Alexander Fleming’s penicillin, the world’s first antibiotic. They may also think…
The pharmaceutical company AveXis recently presented the latest data about its clinical trial for AVXS-101, a gene therapy for infants with type 1…
Spinal muscular atrophy (SMA) is a genetic disease that causes gradual muscle wastage. Patients with SMA will have professionals from various…
Spinal muscular atrophy (SMA) patients are susceptible to lung infections which can often lead to hospitalization. According to the…
Children with spinal muscular atrophy type 1 will experience breathing difficulties and will require a personalized respiratory care plan. There…
Cure SMA has launched a series of care booklets covering a wide range of topics for…
Cure SMA has released a booklet highlighting the importance of clinical trials for research into better…
As the weather turns warmer, many families will be thinking about vacations and traveling. While traveling with a child with…
Breathing issues for infants with spinal muscular atrophy (SMA) can cause serious illness and are the leading cause of death…
Get regular updates to your inbox.